Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced ...

J.P. Morgan turned cautious on the eVTOL sector as it attempted to balance the near-term relativeshare price outperformance ...

About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide ...

LAS VEGAS, NV / ACCESSWIRE / / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its engagement in key events ...

Fully Enrolled Second Cohort in Phase 2 Basket Study of WAL0921 In Chronic Kidney Disease Plans to Initiate Rare Kidney Diseases Cohort in Early 2025 Company to Attend 43rd Annual J.P. Morgan ...

More than 8,000 healthcare professionals will descend on San Francisco starting Monday for the 43rd annual J.P. Morgan ...

The fires, which are still not under control and have killed at least five people, are likely to cost more than $50 billion in overall losses, the analysts said. Late Thursday, Accuweather pinned the ...

The Los Angeles wildfires are now expected to exceed $20B, J.P. Morgan analyst Jimmy Bhullar estimated Thursday, doubling his ...

The $13.7 billion iShares U.S. Equity Factor Rotation Active ETF from BlackRock added $11.7 billion in assets in 2024 after ...

A preliminary report by Accuweather estimated the cost of the wildfires ravaging L.A. County at more than $50 billion, a ...

JPMorgan Income ETF’s JPIE experienced, specialized, and collaborative team earned it a People Pillar rating boost to High, ...

The fires sweeping across Los Angeles are now on track to cause about $20 billion of insured losses, according to an estimate ...